ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,262.75
-0.15%
Dow Jones
38,318.32
-0.95%
Gold vs US Dollar
2,351.855
1.05%
Brent Oil
78.295
-3.11%
Bitcoin
69,141.66
2.06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. RenovoRx Inc (RNXT)

  7. RenovoRx Inc (RNXT) News

RenovoRx (RNXT)

RenovoRx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNXT
DateTimeSourceHeadlineSymbolCompany
30/05/202413:30Business WireRenovoRx CEO Issues Update Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
21/05/202414:00Business WirePublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryNASDAQ:RNXTRenovoRx Inc
14/05/202414:00Business WireRenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024NASDAQ:RNXTRenovoRx Inc
13/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
13/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
10/05/202422:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
10/05/202421:50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
10/05/202421:47Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
02/05/202414:00Business WireRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024NASDAQ:RNXTRenovoRx Inc
18/04/202413:30Business WireRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity RequirementNASDAQ:RNXTRenovoRx Inc
16/04/202413:30Business WireRenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingNASDAQ:RNXTRenovoRx Inc
15/04/202413:00Business WireRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026NASDAQ:RNXTRenovoRx Inc
08/04/202413:30Business WireRenovoRx Announces $11.1 Million at Market Private PlacementNASDAQ:RNXTRenovoRx Inc
05/04/202413:30Business WireRenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024NASDAQ:RNXTRenovoRx Inc
12/03/202413:00Business WireRenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024NASDAQ:RNXTRenovoRx Inc
08/03/202421:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202421:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202421:05Business WireRenovoRx Highlights Key Leadership PromotionsNASDAQ:RNXTRenovoRx Inc
13/02/202400:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
13/02/202400:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
09/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
09/02/202421:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RNXTRenovoRx Inc
06/02/202413:30Business WireRenovoRx CEO Issues Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
31/01/202400:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
30/01/202423:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
30/01/202423:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
30/01/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
29/01/202414:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
29/01/202413:30Business WireRenovoRx Closes $6.1 Million Private PlacementNASDAQ:RNXTRenovoRx Inc
24/01/202402:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
 Showing the most relevant articles for your search:NASDAQ:RNXT

Your Recent History

BIT
P1MG26
BNP Paribas Issuance
LSE
LLOY
Lloyds Banking
NASDAQ
TQQQ
ProShares UltraPro QQQ
NYSE
GHC
Graham
ASX
BIQ
Building IQ
ASX
YSSO
SPDR Small Ords Ein
LSE
85XH
Hsbc Bk. 23
LSE
HJ43
Citi Fun 25
NYSE
JPM-L
JP Morgan Chase
ASX
BHPKOS
LSE
ZX69
Citi Fun 24
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved